170 related articles for article (PubMed ID: 2667681)
1. Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro.
Franco-Cereceda A
Br J Pharmacol; 1989 Jul; 97(3):968-72. PubMed ID: 2667681
[TBL] [Abstract][Full Text] [Related]
2. Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium.
Pernow J
Br J Pharmacol; 1989 Jul; 97(3):983-9. PubMed ID: 2474355
[TBL] [Abstract][Full Text] [Related]
3. Endothelin causes contraction of canine and bovine arterial smooth muscle in vitro and in vivo.
Suzuki Y; Satoh S; Ikegaki I; Asano T; Shibuya M; Sugita K; Lederis K; Rorstad O
Acta Neurochir (Wien); 1990; 104(1-2):42-7. PubMed ID: 2201171
[TBL] [Abstract][Full Text] [Related]
4. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
5. Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.
Mejia JA; Pernow J; von Holst H; Rudehill A; Lundberg JM
J Neurosurg; 1988 Dec; 69(6):913-8. PubMed ID: 2461438
[TBL] [Abstract][Full Text] [Related]
6. Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle.
Goto K; Kasuya Y; Matsuki N; Takuwa Y; Kurihara H; Ishikawa T; Kimura S; Yanagisawa M; Masaki T
Proc Natl Acad Sci U S A; 1989 May; 86(10):3915-8. PubMed ID: 2542956
[TBL] [Abstract][Full Text] [Related]
7. Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels.
Fried G; Samuelson U
Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1330-6. PubMed ID: 2035576
[TBL] [Abstract][Full Text] [Related]
8. Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries.
Prieto D; García-Sacristán A; Simonsen U
Regul Pept; 1998 Sep; 75-76():155-60. PubMed ID: 9802404
[TBL] [Abstract][Full Text] [Related]
9. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.
Douglas SA; Hiley CR
Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471
[TBL] [Abstract][Full Text] [Related]
11. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail.
MacLean MR; McGrath JC
Br J Pharmacol; 1990 Sep; 101(1):205-11. PubMed ID: 2178016
[TBL] [Abstract][Full Text] [Related]
12. Effect of endothelin on normal and diseased human coronary arteries.
Chester AH; O'Neil GS; Allen SP; Luu TN; Tadjkarimi S; Yacoub MH
Eur J Clin Invest; 1992 Mar; 22(3):210-3. PubMed ID: 1582446
[TBL] [Abstract][Full Text] [Related]
13. Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.
Prieto D; Benedito S; Simonsen U; Nyborg NC
Br J Pharmacol; 1991 Mar; 102(3):754-8. PubMed ID: 1364848
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover.
Kasuya Y; Takuwa Y; Yanagisawa M; Kimura S; Goto K; Masaki T
Biochem Biophys Res Commun; 1989 Jun; 161(3):1049-55. PubMed ID: 2545192
[TBL] [Abstract][Full Text] [Related]
15. Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine.
Corr L; Burnstock G; Poole-Wilson P
Peptides; 1993; 14(2):359-64. PubMed ID: 8483814
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of contraction to endothelin in isolated porcine coronary artery.
Kasuya Y; Ishikawa T; Yanagisawa M; Kimura S; Goto K; Masaki T
Am J Physiol; 1989 Dec; 257(6 Pt 2):H1828-35. PubMed ID: 2481402
[TBL] [Abstract][Full Text] [Related]
17. Endothelins: vasoconstrictor effects and localization in canine cerebral arteries.
Saito A; Shiba R; Yanagisawa M; Masaki T; Kimura S; Yamada K; Mima T; Shigeno T; Goto K
Br J Pharmacol; 1991 May; 103(1):1129-35. PubMed ID: 1878750
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of altered contractile responses to vasopressin and endothelin in canine coronary collateral arteries.
Rapps JA; Jones AW; Sturek M; Magliola L; Parker JL
Circulation; 1997 Jan; 95(1):231-9. PubMed ID: 8994441
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
